Advertisement
Advertisement

KOD

KOD logo

Kodiak Sciences Inc Common Stock

41.35
USD
Sponsored
+1.37
+3.43%
Aug 14, 15:59 UTC -4
Closed
exchange

After-Market

41.40

+0.05
+0.12%

Kodiak Sciences Inc Common Stock Profile

About

Kodiak Sciences Inc. is a clinical stage biopharmaceutical company engaged in developing novel therapeutics to treat chronic, high-prevalence retinal diseases, which are the major causes of blindness. The company's proprietary antibody biopolymer conjugate (ABC) platform is designed to maintain potent and effective drug levels in ocular tissues for longer periods than the currently-marketed biologic medicines for treating retinal diseases.

Info & Links

CEO

Victor Perlroth

Headquarters

1250 PAGE MILL ROAD
PALO ALTO, CA 94304, UNITED STATES

Industry

Medical Biomedical And Genetics

Sector

Medical

Website

www.kodiak.com

Auditor

PricewaterhouseCoopers LLP

Share holders

21

Employees

124

Kodiak Sciences Inc Common Stock Statistics

Valuation Measures

Market Capitalization2

2.60B

Enterprise Value

2.48B

Enterprise Value/EBITDA(ttm)

-11.21

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

--

Price to Book(mrq)

22.93

Price to Cash(ytd)

--

Profitability

Gross Margin(ttm)

0.00%

Operating Margin(ttm)

--

Profit Margin(ttm)

0.00%

Return on Equity(ttm)

-247.63%

Return on Invested Capital(ttm)

-454.77%

Return on Assets(ttm)

-82.91%

Income Statement

Revenue(ttm)

0.00

Revenue Per Share(ttm)

0.00

Gross Profit(ttm)

0.00

EBITDA(ttm)3

-220.84M

Net Income Available to Common(ttm)

-241.99M

Diluted EPS(ttm)

-4.19

Share Statistics

Beta (5Y Monthly)

2.21

52-Week Change

291.20%

S&P 500 52-Week Change

20.73%

S&P 500 Member

No

Stock Optionable

Yes

Total Shares Outstanding1

62.85M

Dividend Yield

0.00%

Float4

34.79M

% Held by Insiders

44.40%

% Held by Institutions

89.06%

Balance Sheet

Total Cash(mrq)

125.90M

Total Cash Per Share(mrq)

2.00

Total Debt(mrq)

0.00

Total Debt/Equity(mrq)

0.00%

Current Ratio(mrq)

2.49%

Quick Ratio(mrq)

3.54%

Book Value Per Share(mrq)

0.97

Cash Flow

Operating Cash Flow Per Share(ytd)

-1.38

Free Cash Flow(ytd)

-87.54M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement